FDA Inspection 1031987 — Stephen S. Gottleib, MD

Stephen S. Gottleib, MD — FEI 3013675710

The FDA completed an inspection of Stephen S. Gottleib, MD on Nov 13, 2017 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 13, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Baltimore, MD (United States)

Additional Details

Clinical Investigator (CI)